Giuseppe Ciaramella - 14 Oct 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
President
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
14 Oct 2024
Net transactions value
-$1,259,158
Form type
4
Filing time
16 Oct 2024, 16:44:00 UTC
Previous filing
03 Apr 2024
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $18,303 +27,318 +16% $0.6700 196,934 14 Oct 2024 Direct F1
transaction BEAM Common Stock Options Exercise $54,771 +12,979 +6.6% $4.22 209,913 14 Oct 2024 Direct F1
transaction BEAM Common Stock Options Exercise $10,520 +1,457 +0.69% $7.22 211,370 14 Oct 2024 Direct F1
transaction BEAM Common Stock Sale $1,342,752 -51,110 -24% $26.27 160,260 14 Oct 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -27,318 -100% $0.000000 0 14 Oct 2024 Comon Stock 27,318 $0.6700 Direct F1
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -12,979 -100% $0.000000 0 14 Oct 2024 Comon Stock 12,979 $4.22 Direct F1
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -1,457 -100% $0.000000 0 14 Oct 2024 Comon Stock 1,457 $7.22 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
F2 The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.56, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 This stock option vested as to 25% on the first anniversary of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option was fully vested.